2nd Interventions in Aging Conference by Kennedy, BK & Partridge, L
2nd interventions in aging conference 
 
Brian K. Kennedy1,2 and Linda Partridge3,4 
 
1 Buck Institute for Research on Aging, Novato, CA 94945 
2 Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National 
University Singapore, 117597, Singapore 
3 Institute for Healthy Ageing and Department of Genetics, Evolution and Environment, 
University College London, London, WC1E 6BT UK 
4 Max Planck Institute for the Biology of Ageing, Köln, 50931, Germany 
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In March 2017, the Second Interventions in Aging Conference was held in Cancun, Mexico 
and organized by Fusion Conferences, Ltd. As meeting organizers, we would like to provide a 
brief overview of the meeting proceedings, which reflect larger views in the aging research 
field about the future directions critical for continued progress. 
 
The meeting, similar to the earlier event in 2015, was focused on interventional strategies. 
One notable difference was that this year’s meeting was much more directed toward 
potential interventions to target human aging. The field has been very successful over the 
last decade in identifying interventions that extend lifespan and healthspan in animal 
models such as yeast, flies, worms, mice and, to some extent, primates. However, the 
primary goal is to employ knowledge from basic aging research to develop novel medical 
strategies aimed at extending human healthspan. Aging is the biggest risk factor for a wide 
range of chronic diseases that, to date, medical strategies have treated as separate entities, 
and as they arise. Yet, aging is driven by a limited number of coordinated pathways that can 
be modulated, and evidence suggests that interventions delaying aging will protect against 
multiple age-related diseases simultaneously [1,2]. Discoveries in basic aging research thus 
point towards a broad-spectrum, preventative, medical strategy for aging-related disease. 
 
There were seven research topics each addressed thematically at the meeting. All were 
chosen because they embody different strategies to target human aging. Each session 
combined talks from Platform speakers with those chosen from submitted abstracts. The 
first and largest theme was targeted toward Organismal Aging, or understanding the 
intrinsic pathways that govern aging of the entire organism. Platform presentations were 
provided by Rozalyn Anderson (University of Wisconsin-Madison), Adam Antebi (Max Planck 
Institute, Köln), Holly Brown-Borg (University of North Dakota), Yuki Ikeno and Nicolas Musi 
(University of Texas Health Sciences Center), Laura Niedernhofer (Scripps Florida), Scott 
Pletcher (University of Michigan), Eline Slagboom (Leiden University Medical Center). The 
interesting aspect of these presentations is that they address strategies to modify aging that 
touch back to research from the early days of aging research while simultaneously pointing 
to novel strategies for future interventions. Dr. Brown- Borg defined new mechanisms 
linking growth hormone signaling to aging, Dr. Ikeno, using mammalian models, re-
evaluated the role of reactive oxygen species; Dr. Niedernhofer presented new evidence for 
links between progeria and normal aging, interpreting these strategies in the context of 
possible interventions that may affect both normal and “premature” aging; Dr. Musi linked 
NFκB signaling to sarcopenia, a major driver of frailty in aging; Dr. Pletcher described fly 
studies to examine the impacts of psychological stress on aging using flies; Dr. Antebi 
discussed novel strategies linking nuclear structure to aging using the classic model 
organism – C. elegans; Dr. Anderson elaborated mechanisms linking calorie restriction to 
lifespan extension in primates; and Dr. Slagboom described strategies to examine the 
impact of aging pathways in elderly human populations. 
 
The second theme was focused on using Stem Cells to target aging, with exciting 
presentations by Heinrich Jasper (Buck Institute for Research on Aging) on aging of epithelial 
stem cells in flies and mice, Emmanuelle Passague (Columbia University) on links between 
metabolism, autophagy and aging in the hematopoietic system and Sara Wickstrom (Max 
Planck Institute, Köln), who discussed focused on how adult stem cells self-organize into 
functional configurations. The third theme, addressing Cellular Mechanisms of Longevity 
Assurance, focused on pathways suspected to modulate aging, including autophagy by 
Malene Hansen (Sanford Burnham Prebys Medical Discovery Institute), mitochondrial 
function and aging with emphasis on the role of small mitochondrial peptides by David Lee 
(University of Southern California), and the hypoxia pathway by Dana Miller (University of 
Washington). 
 
Theme 4 centered on Epigenetics, which is not only becoming a target for intervention in 
aging, but is rapidly becoming a leading candidate for providing biomarkers of biological 
age. Weiwei Dang (Baylor College of Medicine) studied mesenchymal stems cells and 
adipocyte differentiation, elucidating mechanisms leading to activation of the protein 
deacetylase, SIRT1; Dr. Eric Greer (Harvard Medical School/Boston Children’s Hospital) 
evaluated mechanisms leading to transgenerational inheritance of epigenetic marks that 
impact lifespan, John Sedivy (Brown University) described links between the epigenome and 
activation of somatic retrotransposons, and how this activation may drive senescence and 
aging; and Steve Horvath (UCLA) detailed a number of studies further promoting the 
epigenetic clock as a marker of accelerated and delayed aging. 
 
Theme 5 was designed to take a Systems Aging viewpoint. Such a holistic understanding of 
the aging process is in a sense the ultimate goal of the research. Is it possible to understand 
such a complex process as aging not just one gene and pathway at a time but in totality? 
Anne Brunet (Stanford University) discussed strategies to model aging using worms and 
killifish (a short-live vertebrate gaining popularity in the aging research field); Paul Robbins 
(Sripps Florida) described studies to target mammalian aging and Christiaan Leeuwenburgh 
(University of Florida) described the multi-fold connections between iron metabolism/ 
transport and aging. The final theme centered on Signaling and Metabolism, hitting the 
major metabolic pathways that are linked to aging and that can be targeted with 
interventional strategies. These include the mTOR pathway and rapalogs, discussed by Matt 
Kaeberlein (University of Washington); dietary restriction and links through mTOR to 
regulation of mRNA splicing, discussed by William Mair (Harvard University), dietary 
restriction in primates discussed by Julie Mattison (National Institute on Aging/NIH), NAD 
metabolism and Sirtuins, discussed by David Sinclair (Harvard Medical School) and 
mitochondrial roles in regulating aging and metabolism, discussed by Pinchas Cohen (USC 
Leonard Davis School of Gerontology). 
 
As we move closer to interventions targeting human aging, it is critical to get together and 
discuss the best strategies and the ideal path forward. The meeting in Cancun provided a 
low stress atmosphere where scientists in the aging field could not only share data but take 
the time to think creatively and discuss issues in depth. We as organizers thank the session 
chairs, speakers, poster presenters and attendees, as well as the staff of Fusion 
Conferences, Ltd. for enabling a fascinating meeting. We also look forward to the 3rd 
Interventions in Conference to be held in approximately two years. 
 
The Second Interventions in Aging Conference was organized by Fusion Conferences, Ltd. 
 
The Second Interventions in Aging Conference was sponsored by Aging (www.aging-
us.com). 
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